GRTX
Price:
$0.0381
Market Cap:
$2.07M
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing ...[Read more]
Industry
Biotechnology
IPO Date
2019-11-07
Stock Exchange
NASDAQ
Ticker
GRTX
According to Galera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.63. This represents a change of 12.49% compared to the average of 5.00 of the last 4 quarters.
The mean historical Current Ratio of Galera Therapeutics, Inc. over the last ten years is 6.78. The current 5.63 Current Ratio has changed 8.20% with respect to the historical average. Over the past ten years (40 quarters), GRTX's Current Ratio was at its highest in in the December 2018 quarter at 13.01. The Current Ratio was at its lowest in in the March 2018 quarter at 0.
Average
6.78
Median
5.58
Minimum
2.88
Maximum
13.01
Discovering the peaks and valleys of Galera Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 268.42%
Maximum Annual Current Ratio = 13.01
Minimum Annual Increase = -54.00%
Minimum Annual Current Ratio = 2.88
Year | Current Ratio | Change |
---|---|---|
2023 | 4.36 | 51.49% |
2022 | 2.88 | -51.86% |
2021 | 5.98 | 7.24% |
2020 | 5.58 | -54.00% |
2019 | 12.13 | -6.80% |
2018 | 13.01 | 268.42% |
The current Current Ratio of Galera Therapeutics, Inc. (GRTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.41
5-year avg
6.19
10-year avg
6.78
Galera Therapeutics, Inc.’s Current Ratio is less than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99), greater than PDS Biotechnology Corporation (0.00), less than Inozyme Pharma, Inc. (7.68), greater than HOOKIPA Pharma Inc. (3.26), greater than X4 Pharmaceuticals, Inc. (4.89), less than Acumen Pharmaceuticals, Inc. (10.43), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Amylyx Pharmaceuticals, Inc. (4.55),
Company | Current Ratio | Market cap |
---|---|---|
6.10 | $575.61M | |
32.99 | $491.80M | |
0.00 | $78.19M | |
7.68 | $180.51M | |
3.26 | $20.76M | |
4.89 | $57.64M | |
10.43 | $142.39M | |
14.62 | $1.38B | |
4.55 | $361.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Galera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Galera Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Galera Therapeutics, Inc. (GRTX)?
What is the highest Current Ratio for Galera Therapeutics, Inc. (GRTX)?
What is the 3-year average Current Ratio for Galera Therapeutics, Inc. (GRTX)?
What is the 5-year average Current Ratio for Galera Therapeutics, Inc. (GRTX)?
How does the current Current Ratio for Galera Therapeutics, Inc. (GRTX) compare to its historical average?